Cancer Screening in Canada: What's In, What's Out, What's Coming

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2021 Jan 23

PMID 33483392

Citations 5

Authors

Genevieve Chaput

M Elisabeth Del Giudice

Ed Kucharski

Affiliations

Soon will be listed here.

Citing Articles

Barriers to and facilitators of breast, cervical and colorectal cancer screening and cancer screening histories of Métis people in Alberta, Canada.

Andrew A, Kima J, Rahul C, Letendre A, James A, Chiang B Int J Circumpolar Health. 2024; 83(1):2368766.

PMID: 39612358 PMC: 11188950. DOI: 10.1080/22423982.2024.2368766.

Development and External Validation of Partial Proportional Odds Risk Prediction Models for Cancer Stage at Diagnosis among Males and Females in Canada.

Biziaev T, Aktary M, Wang Q, Chekouo T, Bhatti P, Shack L Cancers (Basel). 2023; 15(14).

PMID: 37509208 PMC: 10377619. DOI: 10.3390/cancers15143545.

Treatment considerations for CAT.

Sardo L, Bayadinova J, Jenkins S Can Oncol Nurs J. 2023; 33(2):288-2291.

PMID: 37152830 PMC: 10155762.

Sardo L, Bayadinova J, Jenkins S Can Oncol Nurs J. 2023; 33(2):292-295.

PMID: 37152818 PMC: 10155761.

Excellent summary of breast cancer recommendations.

Young J Can Fam Physician. 2021; 67(3):157-159.

PMID: 33727372 PMC: 7963006. DOI: 10.46747/cfp.6703157_1.

References

Tammemagi M, Schmidt H, Martel S, McWilliams A, Goffin J, Johnston M . Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol. 2017; 18(11):1523-1531. DOI: 10.1016/S1470-2045(17)30597-1. View

C Grossman D, Curry S, Owens D, Barry M, Davidson K, Doubeni C . Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 319(6):588-594. DOI: 10.1001/jama.2017.21926. View

Leddin D, Lieberman D, Tse F, Barkun A, Abou-Setta A, Marshall J . Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus. Gastroenterology. 2018; 155(5):1325-1347.e3. DOI: 10.1053/j.gastro.2018.08.017. View

Dickinson J, Tsakonas E, Conner Gorber S, Lewin G, Shaw E, Singh H . Recommendations on screening for cervical cancer. CMAJ. 2013; 185(1):35-45. PMC: 3537778. DOI: 10.1503/cmaj.121505. View

Gierada D, Black W, Chiles C, Pinsky P, Yankelevitz D . Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study. Radiol Imaging Cancer. 2020; 2(2):e190058. PMC: 7135238. DOI: 10.1148/rycan.2020190058. View

James N, de Bono J, Spears M, Clarke N, Mason M, Dearnaley D . Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med. 2017; 377(4):338-351. PMC: 5533216. DOI: 10.1056/NEJMoa1702900. View

Dickinson J, Stankiewicz A, Popadiuk C, Pogany L, Onysko J, Miller A . Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006. BMC Public Health. 2012; 12:992. PMC: 3562530. DOI: 10.1186/1471-2458-12-992. View

Panaccione R, Steinhart A, Bressler B, Khanna R, Marshall J, Targownik L . Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease. J Can Assoc Gastroenterol. 2019; 2(3):e1-e34. PMC: 6619415. DOI: 10.1093/jcag/gwz019. View

Bell N, Connor Gorber S, Shane A, Joffres M, Singh H, Dickinson J . Recommendations on screening for prostate cancer with the prostate-specific antigen test. CMAJ. 2014; 186(16):1225-34. PMC: 4216256. DOI: 10.1503/cmaj.140703. View

10.

Bretthauer M, Kaminski M, Loberg M, Zauber A, Regula J, Kuipers E . Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med. 2016; 176(7):894-902. PMC: 5333856. DOI: 10.1001/jamainternmed.2016.0960. View

11.

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A . Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012; 366(8):697-706. DOI: 10.1056/NEJMoa1108895. View

12.

Klarenbach S, Sims-Jones N, Lewin G, Singh H, Theriault G, Tonelli M . Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. CMAJ. 2018; 190(49):E1441-E1451. PMC: 6279444. DOI: 10.1503/cmaj.180463. View

13.

Kistler C, Kirby K, Lee D, Casadei M, Walter L . Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens. Arch Intern Med. 2011; 171(15):1344-51. PMC: 3291514. DOI: 10.1001/archinternmed.2011.206. View

14.

Wilkinson A, Lieberman D, Leontiadis G, Tse F, Barkun A, Abou-Setta A . Colorectal cancer screening for patients with a family history of colorectal cancer or adenomas. Can Fam Physician. 2019; 65(11):784-789. PMC: 6853346. View

15.

. Recommendations on screening for lung cancer. CMAJ. 2016; 188(6):425-432. PMC: 4818132. DOI: 10.1503/cmaj.151421. View

16.

Ilic D, Djulbegovic M, Jung J, Hwang E, Zhou Q, Cleves A . Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018; 362:k3519. PMC: 6283370. DOI: 10.1136/bmj.k3519. View

17.

Melnikow J, Henderson J, Burda B, Senger C, Durbin S, Weyrich M . Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018; 320(7):687-705. DOI: 10.1001/jama.2018.10400. View

18.

. Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016; 188(5):340-348. PMC: 4786388. DOI: 10.1503/cmaj.151125. View

19.

Brenner D, Weir H, Demers A, Ellison L, Louzado C, Shaw A . Projected estimates of cancer in Canada in 2020. CMAJ. 2020; 192(9):E199-E205. PMC: 7055947. DOI: 10.1503/cmaj.191292. View